A randomized, double-blind, placebo-controlled trial and open-label extension study to evaluate the efficacy and safety of pregabalin in the treatment of neuropathic pain associated with human immunodeficiency virus neuropathy

An international multi-centre, randomised, double-blind, placebo controlled trial to evaluate the efficacy and safety of 0.5% and 2% Pro 2000/5 gels for the prevention of vaginally acquired human immunodeficiency virus (HIV) infections

http://isrctn.org/> ◽

10.1186/isrctn64716212 ◽

2012 ◽

Author(s):

Sheena McCormack

Keyword(s):

Human Immunodeficiency Virus ◽

Controlled Trial ◽

Hiv Infections ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Immunodeficiency Virus

Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study

Pediatric Rheumatology ◽

10.1186/s12969-016-0106-4 ◽

2016 ◽

Vol 14 (1) ◽

Cited By ~ 19

Author(s):

Lesley M. Arnold ◽

◽

Kenneth N. Schikler ◽

Lucinda Bateman ◽

Tahira Khan ◽

...

Keyword(s):

Controlled Trial ◽

Extension Study ◽

Open Label ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Efficacy and safety of mirogabalin for the treatment of fibromyalgia: results from three 13-week randomized, double-blind, placebo- and active-controlled, parallel-group studies and a 52-week open-label extension study

Current Medical Research and Opinion ◽

10.1080/03007995.2019.1629757 ◽

2019 ◽

Vol 35 (10) ◽

pp. 1825-1835 ◽

Cited By ~ 3

Author(s):

Lesley M. Arnold ◽

Susan Whitaker ◽

Ching Hsu ◽

David Jacobs ◽

Domenico Merante

Keyword(s):

Extension Study ◽

Efficacy And Safety ◽

Open Label ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group ◽

Efficacy and safety of alogliptin added to sulfonylurea in Japanese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial with an open-label, long-term extension study

Journal of Diabetes Investigation ◽

10.1111/j.2040-1124.2012.00226.x ◽

2012 ◽

Vol 3 (6) ◽

pp. 517-525 ◽

Cited By ~ 24

Author(s):

Yutaka Seino ◽

Shinzo Hiroi ◽

Masashi Hirayama ◽

Kohei Kaku

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Japanese Patients ◽

Extension Study ◽

Efficacy And Safety ◽

Open Label ◽

Double Blind ◽

Efficacy and safety of alogliptin added to pioglitazone in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label long-term extension study

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2011.01460.x ◽

2011 ◽

Vol 13 (11) ◽

pp. 1028-1035 ◽

Cited By ~ 51

Author(s):

K. Kaku ◽

T. Itayasu ◽

S. Hiroi ◽

M. Hirayama ◽

Y. Seino

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Japanese Patients ◽

Extension Study ◽

Efficacy And Safety ◽

Open Label ◽

Double Blind ◽

PP7.5 – 1768 Efficacy of long-term adjunctive zonisamide therapy in paediatric patients with partial epilepsy: results of an open-label extension study of a Phase III, randomised, double-blind, placebo-controlled trial

European Journal of Paediatric Neurology ◽

10.1016/s1090-3798(13)70165-x ◽

2013 ◽

Vol 17 ◽

pp. S49 ◽

Cited By ~ 1

Author(s):

A Rosati ◽

L Giorgi ◽

K Bradshaw ◽

R Guerrini

Keyword(s):

Controlled Trial ◽

Partial Epilepsy ◽

Phase Iii ◽

Extension Study ◽

Open Label ◽

Double Blind ◽

Double Blind Placebo ◽

Paediatric Patients ◽

Efficacy and safety of alogliptin added to metformin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label, long-term extension study

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2012.01620.x ◽

2012 ◽

Vol 14 (10) ◽

pp. 927-936 ◽

Cited By ~ 39

Author(s):

Y. Seino ◽

Y. Miyata ◽

S. Hiroi ◽

M. Hirayama ◽

K. Kaku

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Japanese Patients ◽

Extension Study ◽

Efficacy And Safety ◽

Open Label ◽

Double Blind ◽

Oxcarbazepine adjunctive therapy for partial seizures in Japanese pediatric patients: a randomized double-blind placebo-controlled study and open-label extension study

Epilepsy & Seizure ◽

10.3805/eands.11.30 ◽

2019 ◽

Vol 11 (1) ◽

pp. 30-45

Author(s):

Tateki Fujiwara ◽

Rie Teshima ◽

Ikuo Sugiyama ◽

Ken Tsuchida ◽

Yoko Ohtsuka

Keyword(s):

Adjunctive Therapy ◽

Pediatric Patients ◽

Extension Study ◽

Controlled Study ◽

Partial Seizures ◽

Open Label ◽

Double Blind ◽

Double Blind Placebo ◽

A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of Gabapentin Enacarbil in Subjects With Neuropathic Pain Associated With Postherpetic Neuralgia (PXN110748)

Journal of Pain ◽

10.1016/j.jpain.2013.01.768 ◽

2013 ◽

Vol 14 (6) ◽

pp. 590-603 ◽

Cited By ~ 26

Author(s):

Lixin Zhang ◽

Michelle Rainka ◽

Roy Freeman ◽

R. Norman Harden ◽

Christopher F. Bell ◽

...

Keyword(s):

Neuropathic Pain ◽

Postherpetic Neuralgia ◽

Controlled Trial ◽

Efficacy And Safety ◽

Gabapentin Enacarbil ◽

Double Blind ◽

Efficacy and safety of esmirtazapine in adult outpatients with chronic primary insomnia: a randomized, double-blind placebo-controlled study and open-label extension

Journal of Clinical Sleep Medicine ◽

10.5664/jcsm.8526 ◽

2020 ◽

Vol 16 (9) ◽

pp. 1455-1467 ◽

Cited By ~ 2

Author(s):

Neely Ivgy-May ◽

Goeran Hajak ◽

Gonnie van Osta ◽

Sabine Braat ◽

Qing Chang ◽

...

Keyword(s):

Primary Insomnia ◽

Controlled Study ◽

Efficacy And Safety ◽

Open Label ◽

Double Blind ◽

Double Blind Placebo ◽